Topics

Eagle Pharmaceuticals Receives Final FDA Approval for Pemfexy (Pemetrexed for Injection)

16:41 EST 11 Feb 2020 | Speciality Pharma Journal

WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that it has received final approval from the U.S. Food and Drug Administration (“FDA”) for its novel product, PEMFEXY™ (pemetrexed for injection), a branded alternative to ALIMTA®. “We are pleased to receive final approval from FDA and look forward to making …

Original Article: Eagle Pharmaceuticals Receives Final FDA Approval for Pemfexy (Pemetrexed for Injection)

NEXT ARTICLE

More From BioPortfolio on "Eagle Pharmaceuticals Receives Final FDA Approval for Pemfexy (Pemetrexed for Injection)"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...